Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis

@inproceedings{Bamias2016OutcomeOP,
  title={Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis},
  author={Aristotelis Bamias and Petros Tsantoulis and Thomas Zilli and Athanasios George Papatsoris and Francesca Caparrotti and Christos Kyratsas and Kimon Tzannis and Kostas Stravodimos and Michail Chrisofos and Gregory J. Wirth and Andreas A Skolarikos and Dionisios N. Mitropoulos and Constantinos A. Constantinides and Charalambos N Deliveliotis and Christophe E. Iselin and Raymond Miralbell and Pierre‐Yves Dietrich and Meletios Athanasios Dimopoulos},
  booktitle={Cancer medicine},
  year={2016}
}
Transurethral resection of bladder tumor (TURBT), radiotherapy, chemotherapy, or combinations can be used in patients with muscle-invasive bladder cancer (MIBC) not undergoing cystectomy. Nevertheless, unfitness for cystectomy is frequently associated with unfitness for other therapeutic modalities. We report the outcome of patients with MIBC who did not undergo cystectomy and did not receive cisplatin-based chemotherapy. Selection criteria for the study were nonmetastatic MIBC, no cystectomy… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Similar Papers

Loading similar papers…